Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

Inhale/Centeon agreement for alpha1-proteinase inhibitor

Jan. 15, 1997

FDA proposes withdrawal of terfenadine products

Jan. 15, 1997

New PDE IV/TNF inhibitors from Chiroscience

Jan. 15, 1997

PDE IV inhibitors revealed by Byk Gulden

Jan. 15, 1997

Ventus progressing well in phase III

Jan. 13, 1997

Bio-Technology General's OxSODrol tested for safety and efficacy

Jan. 13, 1997

French investigators announce success of gene therapy for CF

Jan. 13, 1997

Dual TNF/PDE IV inhibitors described by Chiroscience

Jan. 13, 1997

RPR seeks FDA approval for Nasacort-HFA

Jan. 10, 1997

SciClone cystic fibrosis drug cleared for clinical testing

Jan. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...